Clinical Trials Browser

Phase 1/2 × Brain Neoplasms × pyrotinib × Clear all

NCT04582968 2023-01-18

Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases

Phase 1/2 Unknown

Brain Neoplasms, Breast Neoplasms